beta
Trial Radar AI
Clinical Trial NCT07501871 (DMTA-CH) for Cancer, Chemotherapy is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Digital Media Use and Treatment Adherence in Chemotherapy Patients (DMTA-CH) 80 Observational

Not yet recruiting
Clinical Trial NCT07501871 (DMTA-CH) is an observational study for Cancer, Chemotherapy and is currently not yet recruiting. Enrollment is planned to begin on April 1, 2026 and continue until the study accrues 80 participants. Led by Fenerbahce University, this study is expected to complete by May 1, 2026. The latest data from ClinicalTrials.gov was last updated on March 30, 2026.
Brief Summary
This study aims to examine the relationship between digital media use and treatment adherence in patients receiving chemotherapy. Digital media has become an important tool for accessing health information, participating in support networks, and managing treatment processes. However, the extent to which digital media use affects treatment adherence in oncology patients remains unclear.

This observational study will ...

Show More
Detailed Description
Cancer is a major global health problem and chemotherapy is one of the most commonly used treatment methods. Treatment adherence is critical for achieving optimal outcomes, yet many patients experience difficulties maintaining adherence due to physical, psychological, and social factors.

With the increasing use of digital media, patients are more likely to access health-related information, communicate with healthca...

Show More
Official Title

The Effect of Digital Media Use on Treatment Adherence in Patients Receiving Chemotherapy

Conditions
CancerChemotherapy
Other Study IDs
  • DMTA-CH
  • ASG-YILDIZ-002
NCT ID Number
NCT07501871
Start Date (Actual)
2026-04-01
Last Update Posted
2026-03-30
Completion Date (Estimated)
2026-05-01
Enrollment (Estimated)
80
Study Type
Observational
Status
Not yet recruiting
Keywords
Oncology Nursing
Digital Media
eHealth Literacy
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Chemotherapy Patients
Patients receiving chemotherapy whose digital media use and treatment adherence are assessed.
No Intervention (Observational Study)
This is an observational study with no assigned intervention. Data will be collected through surveys assessing digital media use and treatment adherence.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Treatment Adherence Level
Treatment adherence will be assessed using a validated self-report scale (e.g., Morisky Medication Adherence Scale - MMAS-8).
At baseline (during chemotherapy treatment)
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Digital Media Use Level
Digital media use will be evaluated based on frequency, duration, and purpose of use through a structured questionnaire.
At baseline
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Patients aged between 18 and 65 years
  • Receiving chemotherapy treatment
  • Able to communicate and understand the study procedures
  • Voluntarily agree to participate in the study

  • Patients under 18 or over 65 years of age
  • Patients with cognitive impairment or communication difficulties
  • Patients who refuse to participate
  • Patients with incomplete questionnaire responses
Fenerbahce University logoFenerbahce University
Study Responsible Party
Emine I Yıldız, Principal Investigator, Research Nurse, Fenerbahce University
Study Central Contact
Contact: Emine Ilayda Yildiz, RN, +905436411944, [email protected]
No location data.